Live Watch: Treasury Secretary Bessent testifies before House committee Dusseldorf - Delayed Quote • EUR Pacific Biosciences of California Inc (P09.DU) Follow Add holdings 0.9601 -0.0003 (-0.03%) As of 4:00:11 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for P09.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: P09.DU View More All News Press Releases SEC Filings PacBio (PACB) Q1 Earnings: What To Expect First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry 1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa Positive week for Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional investors who lost 57% over the past year PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million PacBio Grants Equity Incentive Award to New Employee